A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833

Clinical trial NCT05364255 · COMPLETED

Trial details

NCT number: NCT05364255
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

ER-positive, HER2-negative Breast Cancer

Start date: 2022-05-10
Primary completion: 2022-06-20
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.